287
Participants
Start Date
October 7, 2020
Primary Completion Date
August 7, 2023
Study Completion Date
October 30, 2023
Crofelemer 125 MG [Mytesi]
Randomized, Double-blind, Placebo-controlled, two arm trial
Placebo
Matching placebo tablets
Changhua Christian Hospital, Changhua
Fleischer Medical Center, Buenos Aires
Center of Nuclear and Molecular Medicine of Entre Rios (CEMENER), Paraná
9 of July Sanatorium, San Miguel de Tucumán
Jacobi Medical Center, The Bronx
National Cancer Research Center, Belgrade
North Shore Hematology Oncology Associates dba New York Cancer and Blood Specialists, Port Jefferson Station
American Oncology Partners of Maryland, Bethesda
Institute of Pulmonary Diseases of Vojvodina, Kamenitz
Oncology Institute of Vojvodina (IOV), Kamenitz
Inova Schar Cancer Institute, Fairfax
Shenandoah Oncology Associates, Winchester
Cancer Care Centers of Brevard, Inc., Palm Bay
GenesisCare USA, Aventura
BRCR Global, Plantation
Advanced Research Institute, St. Petersburg
The West Clinic Research, Germantown
Gabrail Cancer Research, Canton
Minnesota Oncology Hematology, P.A., Minneapolis
Nebraska Methodist Hospital, Omaha
Texas Oncology - Denison, Denison
Texas Oncology, P.A. - Flower Mound, Flower Mound
MD Anderson Cancer Center, Houston
Texas Oncology - Gulf Coast, Webster
Texas Oncology - New Braunfels, New Braunfels
SCL Health Research Institute, Lafayette
Arizona Oncology Associates PC - HAL, Prescott
PIH Health Whittier Hospital, Whittier
The Oncology Institute of Hope and Innovation, Glendale
Pacific Cancer Medical Center Inc, Anaheim
The Oncology Institute of Hope and Innovation, Corona
Oregon Health & Science University (OHSU) Knight Cancer Institute, Portland
MultiCare Institute for Research and Innovation, Tacoma
National Taiwan University Hospital, Taipei
Taipei Veterans General Hospital, Taipei
China Medical University Hospital, Taichung
Chi Mei Medical Center - LiouYing Branch, Tainan City
Texas Oncology - Plano East, Plano
Medical Center Austral, Buenos Aires
Buenos Aires British Hospital, Buenos Aires
Cordoba Oncology Institute (IONC), Córdoba
CEDIT Diagnostic and Treatment Center, Salta
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City
Isis Specialized Clinic, Santa Fe
"LLC Todua Clinic", Tbilisi
Archangel St. Michael Multiprofile Clinical Hospital LTD, Tbilisi
JSC K. Eristavi National Center of Experimental and Clinical Surgery, Tbilisi
Malkhaz Katsiashvili Multiprofile Emergency Medicine Center LLC, Tbilisi
LTD Caucasus Medical Centre, Tbilisi
Clinical Hospital Center Bezanijska Kosa, Belgrade
University Clinical Center Kragujevac, Kragujevac
University Clinical Center Nis, Niš
Lead Sponsor
Napo Pharmaceuticals, Inc.
INDUSTRY